Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?

Yun Bin Lee, Jeong-Hoon Lee

Clin Mol Hepatol. 2017;23(3):219-221. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0045

View: 7630 Download: 152 Web of Science: 1 Crossref: 2

Review

Current status of and strategies for hepatitis C control in South Korea

Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim

Clin Mol Hepatol. 2017;23(3):212-218. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0105

View: 8011 Download: 232 Web of Science: 17 Crossref: 19

Current status and strategies for hepatitis B control in Korea

Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim

Clin Mol Hepatol. 2017;23(3):205-211. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0104

View: 12503 Download: 287 Web of Science: 84 Crossref: 83

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 8934 Download: 206 Web of Science: 18 Crossref: 19

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 8558 Download: 242 Web of Science: 19 Crossref: 19

Case Report

Development of autoimmune hepatitis in a psoriasis patient without immunosuppressive therapy

Wonyong Jo, Young-Sun Suh, Sang-Il Lee, Yun-Hong Cheon, Jeongmin Hong, Sang Su Lee, Ji Eun Kim, Gyung Hyuck Ko, Hyun-Ok Kim

Clin Mol Hepatol. 2017;23(2):184-187. Published online May 8, 2017

DOI: https://doi.org/10.3350/cmh.2016.0035

View: 7173 Download: 114 Web of Science: 3 Crossref: 1

Original Article

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9389 Download: 218 Web of Science: 50 Crossref: 44

Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B

Hee Yeon Seo, Han Ah Lee, Soon Young Ko, Joon Ho Wang, Jeong Han Kim, Won Hyeok Choe, So Young Kwon

Clin Mol Hepatol. 2017;23(2):154-159. Published online May 8, 2017

DOI: https://doi.org/10.3350/cmh.2016.0067

View: 7368 Download: 170 Web of Science: 7 Crossref: 7

Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis

Oidov Baatarkhuu, Hye Won Lee, Jacob George, Dashchirev Munkh-Orshikh, Baasankhuu Enkhtuvshin, Sosorbaram Ariunaa, Mohammed Eslam, Sang Hoon Ahn, Kwang-Hyub Han, Do Young Kim

Clin Mol Hepatol. 2017;23(2):147-153. Published online May 2, 2017

DOI: https://doi.org/10.3350/cmh.2016.0055

View: 9109 Download: 171 Web of Science: 6 Crossref: 7

Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma

Mingkuan Su, Jianfeng Guo, Jiancheng Huang

Clin Mol Hepatol. 2017;23(2):138-146. Published online April 21, 2017

DOI: https://doi.org/10.3350/cmh.2016.0083

View: 8992 Download: 112 Web of Science: 4 Crossref: 3

Editorial

Is alanine aminotransferase flare-up in nucleos(t)ide analogue treatment of chronic hepatitis B a promising, rather than a devastating, sign?

Nae-Yun Heo

Clin Mol Hepatol. 2017;23(2):125-127. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0106

View: 7079 Download: 141 Web of Science: 3 Crossref: 3

Review

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs

Stephen Caldwell

Clin Mol Hepatol. 2017;23(2):103-108. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0103

View: 11958 Download: 473 Web of Science: 30 Crossref: 31

Original Article

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study

Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park

Clin Mol Hepatol. 2017;23(1):74-79. Published online March 3, 2017

DOI: https://doi.org/10.3350/cmh.2016.0052

View: 7508 Download: 147 Web of Science: 2 Crossref: 2

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients

Goh Eun Chung, Eun Ju Cho, Jeong-Hoon Lee, Jeong-ju Yoo, Minjong Lee, Yuri Cho, Dong Hyeon Lee, Hwi Young Kim, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Fabien Zoulim

Clin Mol Hepatol. 2017;23(1):66-73. Published online February 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0060

View: 9822 Download: 167 Web of Science: 12 Crossref: 11

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol. 2017;23(1):51-56. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0053

View: 7891 Download: 211 Web of Science: 12 Crossref: 14

Review

The use of immunosuppression in autoimmune hepatitis: A current literature review

Angela Cropley, Martin Weltman

Clin Mol Hepatol. 2017;23(1):22-26. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0089

View: 29006 Download: 418 Web of Science: 15 Crossref: 18

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 8773 Download: 134 Web of Science: 9 Crossref: 9

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn

Clin Mol Hepatol. 2016;22(4):443-449. Published online November 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0037

View: 9761 Download: 158 Web of Science: 10 Crossref: 8

Editorial

Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?

Byung-Cheol Song

Clin Mol Hepatol. 2016;22(4):439-442. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0108

View: 7473 Download: 111 Web of Science: 1 Crossref: 1

Review

Management of direct antiviral agent failures

María Buti, Rafael Esteban

Clin Mol Hepatol. 2016;22(4):432-438. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0107

View: 11043 Download: 364 Web of Science: 29 Crossref: 27

New perspectives of biomarkers for the management of chronic hepatitis B

Chih-Lin Lin, Jia-Horng Kao

Clin Mol Hepatol. 2016;22(4):423-431. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0069

View: 12853 Download: 545 Web of Science: 48 Crossref: 47

Case Report

A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy

Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song

Clin Mol Hepatol. 2016;22(3):396-399. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0039

View: 16907 Download: 117 Web of Science: 6 Crossref: 8

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0050

View: 10414 Download: 132 Web of Science: 1 Crossref: 2

Original Article

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B

Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um

Clin Mol Hepatol. 2016;22(3):382-389. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0047

View: 11987 Download: 201 Web of Science: 18 Crossref: 19

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection

Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee

Clin Mol Hepatol. 2016;22(3):366-371. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0022

View: 9125 Download: 142 Crossref: 1

Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment

Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi

Clin Mol Hepatol. 2016;22(3):350-358. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0019

View: 8898 Download: 138 Web of Science: 1 Crossref: 1

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11564 Download: 162 Web of Science: 19 Crossref: 19

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 7881 Download: 115 Web of Science: 2 Crossref: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13222 Download: 392 Web of Science: 67 Crossref: 68

Case Report

Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases

Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim

Clin Mol Hepatol. 2016;22(2):286-291. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0066

View: 10165 Download: 175 Web of Science: 11 Crossref: 13

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 5394	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5361	MAFLD: How is it different from NAFLD?
Viewed By 5244	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3924	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3899	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search